Name: Renal Cell Carcinoma: Clinical Management (Current Clinical Urology) (en Inglés)
Price: 144.59 USD
Availability: InStock
Author: Campbell Steven C.|Rini Brian I.
ISBN: 9781493962655

portada Renal Cell Carcinoma: Clinical Management (Current Clinical Urology) (en Inglés)

Formato

Libro Físico

Editorial

Humana

Autor

Campbell Steven C.|Rini Brian I.

Idioma

Inglés

N° páginas

373

Encuadernación

Tapa Blanda

ISBN13

9781493962655

N° edición

Renal Cell Carcinoma: Clinical Management (Current Clinical Urology) (en Inglés)

Campbell Steven C.|Rini Brian I. (Autor) · Humana · Tapa Blanda

Libro Físico

$ 144.59

$ 289.19

Ahorras: $ 144.59

50% descuento

Cantidad
Estado: Nuevo
Quedan 100+ unidades

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 17 de Junio y el Lunes 01 de Julio.

Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Renal Cell Carcinoma: Clinical Management (Current Clinical Urology) (en Inglés)"

Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain are also be discussed.